Inventor · disambiguated record
Jeffrey Brown
Also filed as: BROWN JEFFREY · BROWN JEFFREY L · BROWN JEFFREY LESTER
4 granted patents·15 pending applications·13 citations·filing 2001–2022
69Inventor score
Top patents by PatentIndex Score
19 records- 0175US7338758B2Compositions and methods for the identification, assessment, prevention and therapy of human cancersMAYO FOUNDATION·Filed 2002·Granted Mar 4, 2008·4 cites·4 claims
- 0269US7195868B2Compositions and methods for the identification, assessment, prevention, and therapy of human cancersMILLENNIUM PHARM INC·Filed 2002·Granted Mar 27, 2007·9 cites·16 claims
- 0368US7871775B2Compositions and methods for the identification, assessment, prevention and therapy of human cancersMILLENNIUM PHARM INC·Filed 2007·Granted Jan 18, 2011·0 cites·4 claims
- 0459US2025049955A1Compositons and methods for the treatment of neurological disorders related to glucosylceramidase beta deficiencyVOYAGER THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0558US2024263141A1Tissue Extracts and Related MethodsALLOSOURCE·Filed 2022·Application pending·0 cites
- 0658US2009123474A1Combination of angiopoietin-2 antagonist and of vegf-a, kdr and/or fltl antagonist for treating cancerASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 0757US2023285596A1Compositions and methods for the treatment of niemann-pick type c1 diseaseVOYAGER THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0856US2023227802A1Compositions and methods for the treatment of neurological disorders related to glucosylceramidase beta deficiencyVOYAGER THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0955US2012288497A1Combination of angiopoietin-2 antagonist and of vegf-a, kdr and/or flt1 antagonist for treating cancerBLAKEY DAVID CHARLES·Filed 2012·Application pending·0 cites
- 1055US2012141604A1Novel compositions and methods for the identification, assessment, prevention and therapy of human cancersCLARK EDWIN·Filed 2011·Application pending·0 cites
- 1154US2016251421A1Combination of angiopoietin-2 antagonist and of vegf-a, kdr and/or flt1 antagonist for treating cancerMEDIMMUNE LTD·Filed 2016·Application pending·0 cites
- 1252US2011097321A1Combination of angiopoietin-2 antagonist and of vegf-a, kdr and/or flt1 antagonist for treating cancerASTRAZENECA AB·Filed 2010·Application pending·0 cites
- 1352US2014023654A1Combination of angiopoietin-2 antagonist and of vegf-a, kdr and/or flt1 antagonist for treating cancerMEDLMMUNE LTD·Filed 2013·Application pending·0 cites
- 1450US2022168450A1Treatment of amyotrophic lateral sclerosis and disorders associated with the spinal cordVOYAGER THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1550US2007190550A1Novel compositions and methods for the identification, assessment, prevention, and therapy of human cancersUNIV TEXAS·Filed 2006·Application pending·0 cites
- 1646US8080368B2Compositions and methods for the identification, assessment, prevention and therapy of human cancersCLARK EDWIN·Filed 2010·Granted Dec 20, 2011·0 cites·10 claims
- 1739US2002015956A1Compositions and methods for the identification, assessment, prevention, and therapy of human cancersFiled 2001·Application pending·0 cites
- 1837US2002110815A1Novel genes, compositions and methods for the identification, assessment, prevention, and therapy of human cancersFiled 2001·Application pending·0 cites
- 1931US2002081596A1Compositions and methods for the identification, assessment, prevention, and therapy of human cancersFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jeffrey Brown files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →